Strohhofer, C; Oltean, S; Huttmair, A; Pipp, C; Benedikt, M; Wallner, M; Verheyen, N; Gollmer, J; Ablasser, K; Hanfstingl-Sinz, D; Andorfer, J; Pachinger-Possl, S; Brunner, M; Rogozarski, J; Kolesnik, E.
The SGLT2-inhibitor Empagliflozin improves Parameters of Diastolic Function after Myocardial Infarction measured by Echocardiography-a Single Center Sub Analysis of the EMMY-Trial
WIEN KLIN WOCHENSCHR. 2023; 135: S343-S345.
[Poster]
Web of Science